Aspirin improves endothelial dysfunction in atherosclerosis

Circulation

Volumn 97, Issue 8, 1998, Pages 716-720

  Husain, Syed ^a   Andrews, Neil P ^a   Mulcahy, David ^a   Panza, Julio A ^a   Quyyumi, Arshed A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Aspirin; Atherosclerosis; Endothelium derived factors

Indexed keywords

ACETYLSALICYLIC ACID; NITROPRUSSIDE SODIUM; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; SUBSTANCE P;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; DOPPLER FLOWMETER; DRUG ACTIVITY; ENZYME ACTIVITY; FEMORAL ARTERY; HUMAN; HYPOTHESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; THROMBOCYTE ACTIVATION; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

EID: 0032478097     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.8.716     Document Type: Article

References (52)

1. Fuster V, dyken ML, Vacans PS, Hennekens C. Aspirin as a therapeutic agent in cardiovascular disease. Cirlulation. 1993;87:659-675.
2. Antiplatelet Trials Collaboration. Collaborative overview of randomized trials of amiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81-106.
3. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med. 1981;304:685-691.
4. Vanhoutte PM. The endothelium: modulator of vascular smooth muscle tone. N Engl J Med. 1988;319:512-513.
5. Furchgott RF, Zawadzki JV. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980; 288;373-376.
6. Feletou M, Vanhoutte PM. Endothelium-dependem hyperpolarization of canine coronary smooth muscle. Br J Phamacol. 1988;93:515-524.
7. Palmer RM, Ferrige AG, Moncada S. Nitnc oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987; 327:524-526.
8. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-141.
9. Förstermann U, Neufang B, The endothelium-dependent vasodilator effect of acetylcholine: characterization of the endothelial relaxing factor with inhibitors of arachidonic acid metabolism. Eur J Pharmacol. 1984;103:65-70.
10. Yanagisawa M, Kurhara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
11. DeMey JG, Claeys M, Vanhoutte PM. Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thromboxane and arachidonic acid in the canine femoral artery. J Pharmacol Exp Ther. 1942;222:166-173.
12. 2. J Pharmacol Exp Ther. 1986;236:535-541.
13. Lüscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension. 1986;8:344-348.
14. Lüscher TF, Diedrich D, Weber E, Vanhoutte PM, Buhler FR. Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension. 1988;11:573-578.
15. Miller VM, Vanhoutte PM. Endothelium-dependent contractions to arachidonic acid are mediated by products of cyclooxygenase. Am J Physiol. 1985;248:H432-H437.
16. Katusic ZS, Vanhoutte PM. Superoxide anion is an endothelium-derived contracting factor. Am J Physiol. 1989;257:H33-H37.
17. Katusic ZS, Shepherd JT, Vanhoutte PM. Endothelium-dependent contractions to calcium ionophore A23187, arachidonic acid and acetylcholine in canine basilar arteries. Stroke. 1988;19:476-479.
18. Zeiher AM, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-401.
19. Egashira K, Inou T, Hirooka Y, Yamade A, Maruoka Y, Kai H, Sugimachi M, Suzuki J, Takeshita A. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions.J Clin Invest. 1993;91:29-37.
20. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Panza JA, Cannon RO III. Nitric oxide activity in the human coronary circulation: impact of risk factors for coronary atherosclerosis. J Clin Invest. 1995;95:1747-1755.
21. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, Takeshita A. Effects of age on endothelium-dependent vasodilation of resistance coronary arteries by acetylcholine in humans. Circulation. 1993;88:77-81.
22. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491-497.
23. Zeiher AM, Drexler H, Wollschläger H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation. 1991;84:1984-1992.
24. Kuhn FE, Mohler ER, Satler LF, Reagan K, Lu DY, Rackley CE. Effects of high density lipoprotein on acetylcholine-induced coronary vasoactivity. Am J Cardiol. 1991;25:1425-1430.
25. Penny WF, Rockman H, Long J, Bhargava V, Carrigan K, Ibriham A, Shabetai R, Ross J, Peterson KL. Heterogeneity of vasomotor response to acerylcholine along the human coroiury artery. J Am Coll Cardiol. 1995; 25:1046-1055.
26. Katz SD, Schwarz M, Yuen J, LeJemtel TH. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure: role of endothelium-derived vasodilating: and vasoconstricting factors. Circulation. 1993;88:55-61.
27. Tesfamariam B, Brown ML, Deykin D, Cohen RA. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest. 1990;85:929-932.
28. Tesfamariam B, Brown ML, Deykin D, Cohen RA. Elevated glucose impairs endothelium-dependent relaxations by activating protein kinase C. J Clin Invest. 1991;87:1643-1648.
29. Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, Solomon S, Nikolic SD, Forman R. LeJemtel TH. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol. 1992;19:918-925.
30. Kaiser L. Spickard RC, Olivier NB. Heart failure depresses endothelium-dependent responses in canine femoral artery. Am J Physiol. 1989;256: H962-H967.
31. Doucette JW, Corl D, Payne HM, Flynn AE, Goto M, Nassi M, Segal J. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation. 1992;85:1899-1911.
32. Glantz SA, Slinker BK. Repeated measures. In: Glantz SA. Slinker BK, eds. Primer of Applied Regression and Analysis of Variance. New York, NY: McGraw-Hill; 1990;381-463.
33. SAS Institute Inc. SAS Technical Report p-229 SAS/STST Software: Changes and Enhancements Release 6.07. Cary, NC: SAS Institute: 1992.
34. 2. Am J Physiol. 1989;257: H1327-H1333.
35. Linder L, Kiowski W, Buhler FR, Lüscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation. 1990; 81:1762-1767.
36. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest. 1992;90:2548-2554.
37. Taddei S, Virdis A, Mattel P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993; 21:929-933.
38. Egashira K, Inou T, Yamada A, Hirooka Y, Urabe Y, Nagasawa K, Takeshita A. Heterogenous effects of the endothelium-dependent vasodilation aretylcholine and substance P on the coronary circulation of patients with angiographically normal coronary arteries. Coron Artery Dis. 1992;3:945-952.
39. Quyyumi AA, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon KO III. Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia: comparison of acerylcholine and substance P. Circulation. 1997;95:104-110.
40. Flavahan NA. Atherosclerotic or lipoprotein-induced endothelial dysfunction: potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation. 1992:83:1927-1938.
41. Sagone AL, Husney RM. Oxidation of salicylates by stimulated granulocytes: evidence that these drugs act as free radical scavengers in biological systems. J Immunol. 1987;138:2177-2183.
42. Tesfamariam B, Cohen RA. Free radicals mediate endothelium cell dysfunction caused by elevated glucose. Am J Physiol. 1992;263:H321-H326.
43. Katusic ZS, Schugel J, Consentino F, Vanhoutte PM. Endotheliumdependent contractions to oxygen-derived free radicals in the canine basilar artery. Am J Physiol. 1993:264:H859-H864.
44. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454-456.
45. Vanhoutte PM, Lüscher TF, Graser T, Endothelium-dependem contractions. Blood Vessels. 1991;28:74-83.
46. Quwunii AA, Cannon RO, Panza JA, Diodati JG, Epstein SE. Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation. 1992;86:1864-1871.
47. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO III. Contribution of nitric oxide to metabolic vasodilation in the human heart. Circulation. 1995;92:320-326.
48. Yeung AC, Vekshtein VI, Krantz DS, Vita JA, Ryan TJ, Ganz P, Selwyn AP. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med. 1991;325:1551-1556.
49. Gordon JB, Ganz P, Nabel EG, Fish D, Zebede J, Mudje GH, Alexander RW, Selwyn AP. Atherosclerosis influences the vasomotor response of epicardial coronary aneries to exercise. J Clin Invest. 1989;83:1946-1952.
50. Dakak N, Hussain S, Mulcahy D, Andrews NP, Panza JA, Waclawiw M, Schenke W, Quyyumi AA. Contribution of nitric oxide to reactive hyperemia: import of endothelial dysfunction and effect of L-arginine. Hypertension. In press.
51. Yao S-K, Ober JC, Krishnaswami A, FergusonJJ, Anderson V, Golino P, Buja LM, Willerson JT. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation. 1992;86;1302-1309.
52. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.